Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The combination therapy effectively treats infertility in PCOS without major side effects.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Interferon β from hair cells stops the growth of other hair cells.

Generic Palbociclib is safe and tolerable for treating certain breast cancer types.

Inclisiran is effective at lowering cholesterol.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Gefitinib can cause hair loss without scarring.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Finasteride and flutamide can effectively treat hirsutism, with abdominal hairs showing the most sensitivity to the treatment.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.